Project Details
Description
A Phase 3, Open-Label Study of the Safety of HPN-100 for the Long-Term Treatment of Urea Cycle Disorders (Treat UCD)
| Status | Finished |
|---|---|
| Effective start/end date | 3/23/09 → 12/31/11 |
Funding
- Hyperion Therapeutics
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.